FindOwnerSearch
Brands and Their Owners
Welcome to the Brand page for “AXIOMER”, which is offered here for In the heading, int. cl. 1 and int. cl. 42 should be deleted. in the statement line 5 and lines 10-22, should deleted. in the statement, lines 6-9, should be deleted, except pharmaceutical preparations for the treatment of genetic diseases based on oligonucleotides, rna. in the statement, line 8, before rna for use in should be inserted.;[ pharmaceutical preparations for the treatment, diagnosis and prevention of genetic diseases and disorders; ] pharmaceutical preparations for the treatment of genetic diseases based on oligonucleotides, [ oligoribonucleotides, aptamers, nucleic acid molecules, dna, ] * for use in * rna [, polynucleotides, ribozymes, mirnas, snornas, mrnas or sirnas ];color is not claimed as a feature of the mark.;[ chemical compounds for scientific or research purposes ];[ laboratory research services relating to pharmaceuticals; medical research; pharmaceutical research and development; laboratory research and analysis in the field of medicines; services of biotechnological, chemical and pharmacological laboratories, including scientific and technological research, in relation to the production of chemicals and biotechnological products for use in the preparation of pharmaceuticals; development of pharmaceutical preparations and medicines; development of technologies for the production of pharmaceutical semi finished and/or finished preparations; academic research, medical and biochemical research and development services; chemistry, laboratory technicians' and engineering services; research and development in the field of biotechnology; research into and development and testing of pharmaceutical and biochemical semi- finished products, in particular for use in medicines, research into and development and testing of medicines; development of test systems for pharmaceutical, medical and sanitizing preparations; services development and identification of and research into new drug targets ];.
Its status is currently believed to be active. Its class is unavailable. “AXIOMER” is believed to be currently owned by “ProQR Therapeutics II B.V.”
| Owner: |
PROQR THERAPEUTICS II B.V.
Owner Details |
|---|---|
| Description: |
In the heading, Int. Cl. 1 and Int. Cl. 42 should be deleted. In the statement line 5 and lines 10-22, should deleted. In the statement, lines 6-9, should be deleted, except pharmaceutical preparations for the treatment of genetic diseases based on oligonucleotides, rna. In the statement, line 8, before rna for use in should be inserted.;[ Pharmaceutical preparations for the treatment, diagnosis and prevention of genetic diseases and disorders; ] pharmaceutical preparations for the treatment of genetic diseases based on oligonucleotides, [ oligoribonucleotides, aptamers, nucleic acid molecules, dna, ] * for use in * rna [, polynucleotides, ribozymes, mirnas, snornas, mrnas or sirnas ];Color is not claimed as a feature of the mark.;[ Chemical compounds for scientific or research purposes ];[ Laboratory research services relating to pharmaceuticals; medical research; pharmaceutical research and development; laboratory research and analysis in the field of medicines; services of biotechnological, chemical and pharmacological laboratories, including scientific and technological research, in relation to the production of chemicals and biotechnological products for use in the preparation of pharmaceuticals; development of pharmaceutical preparations and medicines; development of technologies for the production of pharmaceutical semi finished and/or finished preparations; academic research, medical and biochemical research and development services; chemistry, laboratory technicians' and engineering services; research and development in the field of biotechnology; research into and development and testing of pharmaceutical and biochemical semi- finished products, in particular for use in medicines, research into and development and testing of medicines; development of test systems for pharmaceutical, medical and sanitizing preparations; services development and identification of and research into new drug targets ];
|
| Categories: | HEADING |